I can't remember bta releasing a japanese inavir study and then they release a perceived bad study that just looks like the perameters were wrong. You really have to wonder why the heck bta would do this. I have left a call with mgmt to explain. This proyphaix study is in the scheme of things a non event.
But with the way the market is no surprise bta has gone down.
